Publicaciones (44) Publicaciones de María Cristina Martínez Oharriz

2024

  1. Mucus-penetrating and permeation enhancer albumin-based nanoparticles for oral delivery of macromolecules: Application to bevacizumab

    Drug Delivery and Translational Research, Vol. 14, Núm. 5, pp. 1189-1205

2023

  1. Gliadin nanoparticles for oral administration of bioactives: Ex vivo and in vivo investigations

    International Journal of Biological Macromolecules, Vol. 249

  2. Zein-based nanospheres and nanocapsules for the encapsulation and oral delivery of quercetin

    International Journal of Pharmaceutics, Vol. 643

2022

  1. A Comprehensive Study of Gemfibrozil Complexation with β-Cyclodextrins in Aqueous Solution Using Different Analytical Techniques

    International Journal of Molecular Sciences, Vol. 23, Núm. 24

  2. Inclusion complexes of rifampicin with native and derivatized cyclodextrins: In silico modeling, formulation, and characterization

    Pharmaceuticals, Vol. 15, Núm. 1

  3. Role of Microstructure in Drug Release from Chitosan Amorphous Solid Dispersions

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

2021

  1. Human serum albumin as a potential nanocarrier for the oral delivery of therapeutic proteins

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 15-17

2018

  1. Coencapsulation of cyclodextrins into poly(anhydride) nanoparticles to improve the oral administration of glibenclamide. A screening on C. elegans

    Colloids and Surfaces B: Biointerfaces, Vol. 163, pp. 64-72

  2. Cyclodextrin-grafted poly(anhydride) nanoparticles for oral glibenclamide administration. In vivo evaluation using C. elegans

    International Journal of Pharmaceutics, Vol. 547, Núm. 1-2, pp. 97-105

  3. Human serum albumin nanoparticles for ocular delivery of bevacizumab

    International Journal of Pharmaceutics, Vol. 541, Núm. 1-2, pp. 214-223

  4. Pegylated nanoparticles for the oral delivery of nimodipine: Pharmacokinetics and effect on the anxiety and cognition in mice

    International Journal of Pharmaceutics, Vol. 543, Núm. 1-2, pp. 245-256

2017

  1. A combination of nanosystems for the delivery of cancer chemoimmunotherapeutic combinations: 1-Methyltryptophan nanocrystals and paclitaxel nanoparticles

    Pharmacological Research, Vol. 126, pp. 77-83

  2. Nanoaggregation of inclusion complexes of glibenclamide with cyclodextrins

    International Journal of Pharmaceutics, Vol. 519, Núm. 1-2, pp. 263-271

  3. Optimization and evaluation of zein nanoparticles to improve the oral delivery of glibenclamide. In vivo study using C. elegans

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 121, pp. 104-112

  4. Sorption and Release of Natural Phenolic Antioxidants in Different Cyclodextrin Polymers

    Journal of Agricultural and Food Chemistry, Vol. 65, Núm. 24, pp. 4905-4910

  5. Supramolecular structure of glibenclamide and β-cyclodextrins complexes

    International Journal of Pharmaceutics, Vol. 530, Núm. 1-2, pp. 377-386

2014

  1. In vitro release from reverse poloxamine/α-Cyclodextrin matrices: Modelling and comparison of dissolution profiles

    Journal of Pharmaceutical Sciences, Vol. 103, Núm. 1, pp. 197-206

  2. Influence of chitosan and carboxymethylchitosan on the polymorphism and solubilisation of diflunisal

    International Journal of Pharmaceutics, Vol. 467, Núm. 1-2, pp. 19-26

2013

  1. Complexation of tyrosol with cyclodextrins

    Journal of Inclusion Phenomena and Macrocyclic Chemistry

  2. The role of cyclodextrins in ORAC-fluorescence assays. Antioxidant capacity of tyrosol and caffeic acid with hydroxypropyl-β-cyclodextrin

    Journal of Agricultural and Food Chemistry, Vol. 61, Núm. 50, pp. 12260-12264